Cat. No. | Species | Product Description | Structure | Purity | Feature |
---|---|---|---|---|---|
DL3-C52H3 | Cynomolgus | Cynomolgus DLL3 Protein, His Tag | ![]() |
||
DL3-H52H4 | Human | Human DLL3 Protein, His Tag (MALS verified) | ![]() |
![]() ![]() |
|
DL3-H5255 | Human | Human DLL3 Protein, Fc Tag | ![]() |
![]() ![]() |
Please contact us via TechSupport@acrobiosystems.com if you have any question on this product.
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
89Zr-DFO-SC16.56 | 89Zr-DFO-SC16.56 | Phase Ⅰ | Memorial Sloan Kettering Cancer Center | Small cell lung cancer (SCLC) | Details |
HPN-328 | HPN-328 | Phase Ⅱ | Harpoon Therapeutics | Small cell lung cancer (SCLC) | Details |
AMG-119 (Amgen) | Phase Ⅰ | Amgen | Small cell lung cancer (SCLC) | Details | |
AMG-757 | AMG-757 | Phase Ⅰ | Amgen | Small cell lung cancer (SCLC) | Details |
Rovalpituzumab tesirine | SC16LD6.5; SC-0002; P256HB60FF; SC0001-SCX; SC0001SCX | Phase Ⅲ | Abbvie, Stemcentrx | Small cell lung cancer (SCLC), Solid tumours | Details |
This web search service is supported by Google Inc.